Identification of E1AF as a target gene of E2F1-induced apoptosis in response to DNA damage

Journal of Biochemistry

Volumn 144, Issue 4, 2008, Pages 539-546

  Wei, Yuanyan ^a   Liu, Dan ^a   Ge, Yuqing ^a   Zhou, Fengbiao ^a   Xu, Jiejie ^a   Chen, Hong ^a   Gu, Jianxin ^a   Jiang, Jianhai ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; DNA damage; E1AF; E2F1; H1299 cells

Indexed keywords

DNA; ETOPOSIDE; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E1AF; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL STRUCTURE; CONTROLLED STUDY; DNA DAMAGE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA INTERFERENCE; WESTERN BLOTTING;

ADENOVIRUS E1A PROTEINS; APOPTOSIS; BASE SEQUENCE; CELL LINE; DNA DAMAGE; DNA PRIMERS; E2F1 TRANSCRIPTION FACTOR; ETOPOSIDE; GENE EXPRESSION; HUMANS; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE;

EID: 53549084854     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvn098     Document Type: Article

References (47)

1. Shindoh, M., Higashino, F., and Kohgo, T. (2004) E1AF, an Ets-oncogene family transcription factor. Cancer Lett. 216, 1-8
2. Ladle, R. and Frank, E. (2002) The role of the Ets gene PEA3 in the development of motor and sensory neurons. Physiol. Behav. 77, 571-576
3. Laing, M.A., Coonrod, S., Hinton, B.T., Downie, J.W., Tozer, R., Rudnicki, M.A., and Hassell, J.A. (2000) Male sexual dysfunction in mice bearing targeted mutant alleles of the PEA3 ets gene. Mol. Cell. Biol. 20, 9337-9345
4. Kurpios, N.A., Sabolic, N.A., Shepherd, T.G., Fidalgo, G.M., and Hassell, J.A. (2003) Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. J. Mamm. Gland Biol. Neoplasia 8, 177-190
5. Firlej, V., Bocquet, B., Desbiens, X., de Launoit, Y., and Chotteau-Lelievre, A. (2005) Pea3 transcription factor cooperates with USF-1 in regulation of the murine Bax transcription without binding to an Ets-binding site. J. Biol. Chem. 280, 887-898
6. Shepherd, T.G., Kockeritz, L., Szrajber, M.R., Muller, W.J., and Hassell, J.A. (2001) The pea3 subfamily Ets genes are required for HER2/Neu-mediated mammary oncogenesis. Curr. Biol. 11, 1739-1748
7. O'Hagan, R.C. and Hassell, J.A. (1998) The PEA3 Ets transcription factor is a downstream target of the HER2/ Neu receptor tyrosine kinase. Oncogene 16, 301-310
8. Upadhyay, S., Liu, C., Chatterjee, A., Hoque, M.O., Kim, M.S., Engles, J., Westra, W., Trink, B., Ratovitski, E., and Sidransky, D. (2006) LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer. Cancer Res. 66, 7870-7879
9. Hakuma, N., Kinoshita, I., Shimizu, Y., Yamazaki, K., Yoshida, K., Nishimura, M., and Dosaka-Akita, H. (2005) E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells. Cancer Res. 65, 10776-10782
10. Izumiyama, Y., Ohiro, Y., Higashino, F., Yoshida, K., Taguchi, K., Todo, S., Kohgo, T., Totsuka, Y., and Shindoh, M. (2005) E1AF expression is closely correlated with malignant phenotype of tongue squamous cell carcinoma through activation of MT1-MMP gene promoters. Oncology Reports 13, 715-720
11. Davidson, B., Goldberg, I., Tell, L., Vigdorchik, S., Baekelandt, M., Berner, A., Kristensen, G.B., Reich, R., and Kopolovic, J. (2004) The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions. Clin. Exp. Metastasis 21, 191-199
12. Oikawa, T. and Yamada, T. (2003) Molecular biology of the Ets family of transcription factors. Gene 303, 11-34
13. Tahara, E. (2000) Molecular aspects of invasion and metastasis of stomach cancer. Verh. Dtsch. Ges. Pathol. 84, 43-49
14. Taguchi, K., Yoshida, K., Sasaki, F., and Fujinaga, K. (1997) Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines. Jpn J. Cancer Res. 88, 394-400
15. Jiang, J., Wei, Y., Liu, D., Zhou, J., Shen, J., Chen, X., Zhang, S., Kong, X., and Gu, J. (2007) E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription. Biochem. Biophys. Res. Commun. 358, 53-58
16. Jiang, J., Wei, Y., Shen, J., Liu, D., Chen, X., Zhou, J., Zong, H., Yun, X., Kong, X., Zhang, S., Yang, Y., and Gu, J. (2007) Functional interaction of E1AF and Sp1 in glioma invasion. Mol. Cell. Biol. 27, 8770-8782
17. Hata, H., Kitamura, T., Higashino, F., Hida, K., Yoshida, K., Ohiro, Y., Totsuka, Y., Kitagawa, Y., and Shindoh, M. (2008) Expression of E1AF, an Ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene. Oncology Reports 19, 1093-1098
18. Liu, H.Y., Zhou, B., Wang, L., Li, Y., Zhou, Z.G., Sun, X.F., Xu, B., Zeng, Y.J., Song, J.M., Luo, H.Z., and Yang, L. (2007) Association of E1AF mRNA expression with tumor progression and matrilysin in human rectal cancer. Oncology 73, 384-388
19. Funaoka, K., Shindoh, M., Yoshida, K., Hanzawa, M., Hida, K., Nishikata, S., Totsuka, Y., and Fujinaga, K. (1997) Activation of the p21(Waf1/Cip1) promoter by the Ets oncogene family transcription factor E1AF. Biochem. Biophys. Res. Commun. 236, 79-82
20. Menendez, J.A., Vellon, L., and Lupu, R. (2005) Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene. Ann. Oncol. 16, 1253-1267
21. Menendez, J.A., Vellon, L., Mehmi, I., Oza, B.P., Ropero, S., Colomer, R., and Lupu, R. (2004) Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc. Natl Acad. Sci. USA 101, 10715-10720
22. Liu, D., Wei, Y., Zhou, F., Ge, Y., Xu, J., Chen, H., Zhang, W., Yun, X., and Jiang, J. (2008) E1AF promotes mithramycin A-induced Huh-7 cell apoptosis depending on its DNA-binding domain. Arch. Biochem. Biophys. 477, 20-26
23. Norbury, C.J. and Zhivotovsky, B. (2004) DNA damage-induced apoptosis. Oncogene 23, 2797-2808
24. Melino, G. (2002) The meaning of death. Cell Death Differ. 9, 347-348
25. Lin, W.C., Lin, F.T., and Nevins, J.R. (2001) Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15, 1833-1844
26. Stanelle, J. and Putzer, B.M. (2006) E2F1-induced apoptosis: turning killers into therapeutics. Trends Mol. Med. 12, 177-185
27. Bell, L.A. and Ryan, K.M. (2004) Life and death decisions by E2F-1. Cell Death Differ. 11, 137-142
28. Salon, C., Eymin, B., Micheau, O., Chaperot, L., Plumas, J., Brambilla, C., Brambilla, E., and Gazzeri, S. (2006) E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short). Cell Death Differ. 13, 260-272
29. Roos, W.P., Christmann, M., Fraser, S.T., and Kaina, B. (2007) Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O(6)-methylguanine due to high E2F1 regulated mismatch repair. Cell Death Differ. 14, 1422-1432
30. Hershko, T., Chaussepied, M., Oren, M., and Ginsberg, D. (2005) Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ. 12, 377-383
31. Kowalik, T.F., DeGregori, J., Leone, G., Jakoi, L., and Nevins, J.R. (1998) E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ. 9, 113-118
32. Stiewe, T. and Putzer, B.M. (2000) Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat. Genet. 26, 464-469
33. Wang, C., Hou, X., Mohapatra, S., Ma, Y., Cress, W.D., Pledger, W.J., and Chen, J. (2005) Activation of p27Kip1 Expression by E2F1. A negative feedback mechanism. J. Biol. Chem. 280, 12339-12343
34. Moroni, M.C., Hickman, E.S., Lazzerini Denchi, E., Caprara, G., Colli, E., Cecconi, F., Muller, H., and Helin, K. (2001) Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 3, 552-558
35. Garcia, I., Murga, M., Vicario, A., Field, S.J., and Zubiaga, A.M. (2000) A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ. 11, 91-98
36. Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G., Jr., Livingston, D.M., Orkin, S.H., and Greenberg, M.E. (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561
37. Hong, S., Pusapati, R.V., Powers, J.T., and Johnson, D.G. (2006) Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis. Cell Cycle 5, 801-803
38. Jiang, J., Chen, X., Shen, J., Wei, Y., Wu, T., Yang, Y., Wang, H., Zong, H., Yang, J., Zhang, S., Xie, J., Kong, X., Liu, W., and Gu, J. (2006) Beta1,4-galactosyltransferase V functions as a positive growth regulator in glioma. J. Biol. Chem. 281, 9482-9489
39. Ishida, S., Higashino, F., Aoyagi, M., Takahashi, A., Suzuki, T., Shindoh, M., Fujinaga, K., and Yoshida, K. (2006) Genomic structure and promoter activity of the E1AF gene, a member of the Ets oncogene family. Biochem. Biophys. Res. Commun. 339, 325-330
40. Thornborrow, E.C. and Manfredi, J.J. (1999) One mechanism for cell type-specific regulation of the Bax promoter by the tumor suppressor p53 is dictated by the p53 response element. J. Biol. Chem. 274, 33747-33756
41. D'Sa-Eipper, C., Leonard, J.R., Putcha, G., Zheng, T.S., Flavell, R.A., Rakic, P., Kuida, K., and Roth, K.A. (2001) DNA damage-induced neural precursor cell apoptosis requires p53 and caspase 9 but neither Bax nor caspase 3. Development 128, 137-146
42. Zhu, X., Jiang, J., Shen, H., Wang, H., Zong, H., Li, Z., Yang, Y., Niu, Z., Liu, W., Chen, X., Hu, Y., and Gu, J. (2005) Elevated beta1,4- galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator. J. Biol. Chem. 280, 12503-12516
43. Hida, K., Shindoh, M., Yasuda, M., Hanzawa, M., Funaoka, K., Kohgo, T., Amemiya, A., Totsuka, Y., Yoshida, K., and Fujinaga, K. (1997) Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities. Am. J. Pathol. 150, 2125-2132
44. Budihardjo, I., Oliver, H., Lutter, M., Luo, X., and Wang, X. (1999) Biochemical pathways of caspase activation during apoptosis. Ann. Rev. Cell Dev. Biol. 15, 269-290
45. Zimmermann, K.C., Bonzon, C., and Green, D.R. (2001) The machinery of programmed cell death. Pharmacol. Ther. 92, 57-70
46. Lalier, L., Cartron, P.F., Juin, P., Nedelkina, S., Manon, S., Bechinger, B., and Vallette, F.M. (2007) Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12, 887-896
47. Reed, J.C. (2006) Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ. 13, 1378-1386